Antifungal agents. Part I. Amphotericin B preparations and flucytosine

Research output: Contribution to journalArticle

82 Scopus citations

Abstract

Traditionally, amphotericin B has been the cornerstone of antifungal treatment. Toxicity, however, is a major dose-limiting factor of amphotericin B deoxycholate. Nevertheless, it continues to have a major role in the treatment of deep-seated mycotic infections. Recently, less nephrotic lipid formulations, including amphotericin B lipid complex, amphotericin B cholesteryl sulfate, and liposomal amphotericin B, have been introduced. The pharmacologic properties, main indications, recommended dosages, related costs, and adverse effects of these various preparations are summarized in this review. Orally administered flucytosine is useful in certain infections, particularly cryptococcal meningitis, but it should be used with caution in patients with renal insufficiency.

Original languageEnglish (US)
Pages (from-to)1205-1225
Number of pages21
JournalMayo Clinic proceedings
Volume73
Issue number12
DOIs
StatePublished - Jan 1 1998

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Antifungal agents. Part I. Amphotericin B preparations and flucytosine'. Together they form a unique fingerprint.

  • Cite this